Osimertinib (AZD9291) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M, respectively. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer[1].
Molecular Weight:
499.61
Purity:
99.99
CAS Number:
[1421373-65-0]
Formula:
C28H33N7O2
Target:
EGFR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted